🔗 Permalink

Inventor profile of:

Mark Mclaughlin

City:

Tampa, Florida

Country:

United States

Published Applications:

Last publication date:

2024-02-08

Top Assignees for applications by Mark Mclaughlin

The entities that hold a legal rights for patent applications filed by inventor Mclaughlin Mark:

UNIVERSITY OF SOUTH FLORIDA 11 Tampa, FL United States
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. 11 Tampa, FL United States
THE ARIZONA BOARD OF REGENTS, on behalf of THE UNIVERSITY OF ARIZONA 3 Tucson, AZ United States
The Scripps Research Institute 2 La Jolla, CA United States
MODULATION THERAPEUTICS 1 Tampa, FL United States

Recent patent applications by Mclaughlin Mark

Mark Mclaughlin from Tampa, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-02-08

US20240041972A1

Human necessities

CONJUGATES FOR IMMUNOTHERAPY

#2 | 2023-07-06

US20230211022A1

Human necessities

RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R

#3 | 2022-09-08

US20220282215A1

Chemistry; metallurgy

Tumor-infiltrating lymphocytes for adoptive cell therapy

#4 | 2021-07-29

US20210230219A1

Chemistry; metallurgy

Toll-like receptor 2 ligands and methods of making and using thereof

#5 | 2020-06-18

US20200188472A1

Human necessities

CONJUGATES FOR IMMUNOTHERAPY

#6 | 2020-04-09

US20200108159A1

Human necessities

Radiotherapeutic and companion imaging agents to target MC1R

#7 | 2019-08-29

US20190263857A1

Chemistry; metallurgy

Toll-like receptor 2 ligands and methods of making and using thereof

#8 | 2019-06-13

US20190177693A1

Chemistry; metallurgy

Tumor-infiltrating lymphocytes for adoptive cell therapy

#9 | 2019-03-28

US20190092812A1

Chemistry; metallurgy

Cyclic peptide conjugates and methods of use

#10 | 2018-05-10

US20180126013A1

Human necessities

RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R

#11 | 2018-02-22

US20180051055A1

Chemistry; metallurgy

Toll-like receptor 2 ligands and methods of making and using thereof

#12 | 2017-07-20

US20170202902A1

Human necessities

Conjugates for immunotherapy

#13 | 2017-06-22

US20170174726A1

Chemistry; metallurgy

Stabilized peptoid-peptide hybrids and uses thereof

#14 | 2017-03-23

US20170081635A1

Chemistry; metallurgy

TUMOR-INFILTRATING LYMPHOCYTES FOR ADOPTIVE CELL THERAPY

#15 | 2016-09-08

US20160257712A1

Chemistry; metallurgy

Integrin interaction inhibitors for the treatment of cancer

#16 | 2016-08-11

US20160229892A1

Chemistry; metallurgy

Cyclic peptide conjugates and methods of use

#17 | 2015-04-16

US20150105328A1

Chemistry; metallurgy

PEPTOID-PEPTIDE HYBRIDS AND THEIR USE

#18 | 2015-03-12

US20150071918A1

Chemistry; metallurgy

PEPTIDES FOR THE TREATMENT OF CANCER

#19 | 2015-01-15

US20150017259A1

Chemistry; metallurgy

INTEGRIN INTERACTION INHIBITORS FOR THE TREATMENT OF CANCER

#20 | 2014-10-30

US20140322227A1

Chemistry; metallurgy

PEPTIDES FOR TREATMENT OF BONE DEFICIENCY AND AUTOIMMUNE DISORDERS

#21 | 2013-03-14

US20130065837A1

Chemistry; metallurgy

Integrin interaction inhibitors for the treatment of cancer

InventorID:

140834 ⎘